Cochlear implant

Cochlear calls for action in Washington D.C. ahead of World Hearing Day

Retrieved on: 
Wednesday, February 28, 2024
Blood pressure, Bangladesh Technical Education Board, Social isolation, Hearing, General Motors, Cochlear implant, Research, Greater Baltimore Medical Center, NIH, SVP, Quality of life, Ageing, Public health, Loneliness, Risk, Cochlear, World Hearing Day, Health, Hearing loss, Diplomatic mission, Policy, Patient, Family, Child, Speech, Development, Dentistry

WASHINGTON, Feb. 28, 2024 /PRNewswire/ -- Today, Cochlear assembled a team of hearing experts to emphasize the importance of hearing health for policy makers at the Australian Embassy in Washington D.C. ahead of World Hearing Day on Sunday March 3rd.

Key Points: 
  • WASHINGTON, Feb. 28, 2024 /PRNewswire/ -- Today, Cochlear assembled a team of hearing experts to emphasize the importance of hearing health for policy makers at the Australian Embassy in Washington D.C. ahead of World Hearing Day on Sunday March 3rd.
  • "After I took action and received my first cochlear implant in 1993, my life absolutely changed for the better."
  • Echoing Dr. Lin's education messaging, panelist Barbara Kelley, Executive Director of The Hearing Loss Association of America (HLAA) spoke about changing mindsets, urging Americans to protect hearing in noisy environments, check hearing with regular exams and treat hearing loss as soon as possible.
  • "If left unaddressed, hearing loss poses significant challenges to overall health and can be progressive, leading to greater hearing loss over time.

Cochlear™ Osia® System becomes industry's first active bone conduction system to enable MRI at 3 Tesla

Retrieved on: 
Friday, August 18, 2023
Headscarf, ASX, Cochlear implant, Bone conduction, SSD, MRI, Patient, Hearing, Greater Baltimore Medical Center, Diagnosis, SVP, Health Canada, Wood, Medical imaging, Medical device, Cochlear

The new Osia® System with Osia OSI300 Implant enables patients to undergo MRI at 3.0 T without the need for surgery.

Key Points: 
  • The new Osia® System with Osia OSI300 Implant enables patients to undergo MRI at 3.0 T without the need for surgery.
  • The new Osia System offers the proven benefits as the current version: excellent hearing outcomes1, ease of use, discreetness and reliability2.
  • With the introduction of the OSI300 Implant, it is the first and only active bone conduction system that allows patients to undergo MRI scans at both 1.5 T and 3.0 T without the need for surgery3.
  • With the new system, patients with an active bone conduction system can conveniently undergo MRI at 1.5 T and at 3.0 T with no impact to their hearing – MRI should be accessible to everyone" says Dig Howitt, Chief Executive Officer & President of Cochlear.

FDA approves Cochlear's Nucleus 8 Sound Processor, smaller, smarter, better connected cochlear implant technology

Retrieved on: 
Tuesday, November 1, 2022
People, Electronics, Airport, Nucleus, Hearing, Food and Drug Administration, AUD, Research, Family, Industry, Technology, Health Canada, Friends, Hearing loss, ASX, FDA, Bluetooth, Patient, Food, Cochlear implant, Noise, Environment, Sensorineural hearing loss, Medical imaging, Dentistry, Cochlear

LONE TREE, Colo., Nov. 1, 2022 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, receives U.S. Food and Drug Administration (FDA) approval for the Cochlear™ Nucleus® 8 Sound Processor. The Nucleus 8 Sound Processor is now the smallest and lightest behind-the-ear cochlear implant sound processor available in the industry. 1-3 It is also the world's first cochlear implant sound processor ready to provide direct audio connectivity to everyday consumer electronics using the next generation LE Audio technology from Bluetooth®.1-3,#

Key Points: 
  • The Nucleus 8 Sound Processor is now the smallest and lightest behind-the-ear cochlear implant sound processor available in the industry.
  • The Nucleus 8 Sound Processor builds on the direct streaming capabilities available in Cochlear's latest sound processors.
  • In addition to the Nucleus 8 Sound Processor, Cochlear is expanding its Connected Care solutions for Nucleus Implant System recipients.
  • The Nucleus 8 Sound Processor will be commercially available across the United States and Canada by the end of 2022.

Global Electroceuticals / Bioelectric Medicine Industry Report 2022 with Analysis of 50 Players, Including Abbott Labs, Biotronik, Boston Scientific Corp, Cochlear, and Medtronic - ResearchAndMarkets.com

Retrieved on: 
Friday, January 28, 2022
Medical Devices, Health, Surgery, Pharmaceutical, Cardiology, Biotechnology, Growth, Breast implant, Patient, Medtronic, Neurostimulation, Boston Scientific, Cochlear implant, Skin, Technology, Research, COVID-19, Epidural space, CAGR, Cancer, Hearing loss, Biomedicine, Electricity, Arrhythmia, Spinal cord, Cardiovascular disease, Electrode, ICDS, Medical device, Pet

The "Electroceuticals / Bioelectric Medicine - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Electroceuticals / Bioelectric Medicine - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • The heightened pace of research in the area of bioelectric medicine is also likely to boost future business.
  • This segment currently accounts for a 14.8% share of the global Electroceuticals / Bioelectric Medicine market.
  • The presence of leading medical device makers including Boston Scientific Corporation, Medtronic and BIOTRONIK in the region augurs well for the market.

FDA approves Cochlear Nucleus Implants for unilateral hearing loss/single-sided deafness

Retrieved on: 
Tuesday, January 11, 2022
People, Binaural, Patient, Research, Technology, Outline, Hearing, Breast implant, Fatigue, Unilateralism, Cochlear implant, SSD, ASX, Ear, Quality of life, University of North Carolina at Pembroke, Industry, Sensorineural hearing loss, Awareness, AUD, Multimedia, Food and Drug Administration, Noise, Food, Speech, FDA, Hearing loss, Otolaryngology–Head and Neck Surgery, Cochlear nucleus, University, UHL, Medical device, Dentistry, Adult, Neurotology, Cochlear, Solution

LONE TREE, Colo., Jan. 11, 2022 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval of Cochlear Nucleus Implants for the treatment of unilateral hearing loss (UHL)/single-sided deafness (SSD).

Key Points: 
  • LONE TREE, Colo., Jan. 11, 2022 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval of Cochlear Nucleus Implants for the treatment of unilateral hearing loss (UHL)/single-sided deafness (SSD).
  • FDA approves use of a cochlear implant from Cochlear for unilateral hearing loss/single-sided deafness.
  • Now with this approval, Cochlear is proud to offer the most hearing implant options available to those with unilateral hearing loss/single-sided deafness through our cochlear implant and bone conduction solutions," said Christine Menapace, MA, Vice President, Clinical Affairs, Cochlear Americas.
  • Cochlear will now support those with UHL/SSD by offering its cochlear implant, the Cochlear Nucleus System, and bone conduction solutions, the Cochlear Osia System and the Cochlear Baha System.

Insights on the Neurostimulation Devices Global Market to 2026 - Rise in Number of People Suffering from Hearing Loss is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, September 6, 2021
Medical Devices, Health, Medical technology, Branches of biology, Health sciences, Medical devices, Audiology, Otology, Neurotechnology, Neuroprosthetics, Neurostimulation, Implant, Hearing loss, Hearing aid

Neurostimulation is used as a key element in neural prosthetics for hearing aids, artificial vision, artificial limbs, brain-machine interfaces, etc.

Key Points: 
  • Neurostimulation is used as a key element in neural prosthetics for hearing aids, artificial vision, artificial limbs, brain-machine interfaces, etc.
  • the growth in the neurostimulation devices market may be attributed to the increasing prevalence of chronic neuromuscular disorder and the rising adoption of these devices by the physicians.
  • However, stringent regulations of the neurostimulation devices and lack of skilled professionals for performing the surgeries might restrain the market growth during the given time frame.
  • The market is expected to surge in the coming years, due to the rise in the number of people, suffering from hearing loss and other related concerns.

Highland Park Audiologist Adds Cochlear Implant Expert to Staff

Retrieved on: 
Wednesday, August 11, 2021
University of Illinois Urbana-Champaign, Patient, Quality of life, Health, Kool-Aid, Hearing, Program, Champaign County, Illinois, Adult, Environment, Multimedia, University, ENT, Love, Northern Illinois University, Cochlear implant, Medical device, Dentistry, Online shopping

HIGHLAND PARK, N.J., Aug. 11, 2021 /PRNewswire/--Dr. Tran Do has joined the staff of New Jersey audiology practice The Hearing Center, after completing a residency with a focus on cochlear implant patients.

Key Points: 
  • HIGHLAND PARK, N.J., Aug. 11, 2021 /PRNewswire/--Dr. Tran Do has joined the staff of New Jersey audiology practice The Hearing Center, after completing a residency with a focus on cochlear implant patients.
  • "Cochlear implants in a doctor's office make them more accessible to patients who may benefit from them," Dr. Do said.
  • Dr. Do said she first became interested in cochlear implants while working with patients in Chicago as a hearing aid technician.
  • Dr. Sandler said that The Hearing Center's cochlear implant program is what "attracted Dr. Do to The Hearing Center."

Global Cochlear Implants Market Report 2021 Featuring Cochlear Ltd, GN Store Nord, MEDEL Elektromedizinische Gerate, Nurotron Biotechnology, Oticon Medical, Sonova, & William Demant - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 21, 2021
Medical devices, Health, Academic disciplines, Audiology, Bionics, Cochlear implant, Neuroprosthetics, Applied mathematics, Branches of biology, Compound annual growth rate

The "Cochlear Implants - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cochlear Implants - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Unilateral, one of the segments analyzed in the report, is projected to record 7.8% CAGR and reach US$2.3 Billion by the end of the analysis period.
  • The U.S. Market is Estimated at $409.4 Million, While China is Forecast to Grow at 12.5% CAGR
    The Cochlear Implants market in the U.S. is estimated at US$409.4 Million in the year 2020.
  • Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.5% and 7.4% respectively over the 2020-2027 period.

Oticon Medical Announces FDA Premarket Approval for Neuro Cochlear Implant System to Treat Severe to Profound Sensorineural Hearing Loss

Retrieved on: 
Thursday, June 24, 2021
Consumer electronics, Health, FDA, Medical devices, Technology, Other Health, Audio, Video, Medical technology, Audiology, Otology, Branches of biology, Health sciences, Medical devices, Hearing loss, Cochlear implant, Implant, Cochlear, Sensorineural hearing loss, Cochlear Bone Anchored Solutions

With the expansion of its cochlear implant solutions to the US market, Oticon Medical is well positioned to become the worlds leading hearing expert within implantable hearing solutions.

Key Points: 
  • With the expansion of its cochlear implant solutions to the US market, Oticon Medical is well positioned to become the worlds leading hearing expert within implantable hearing solutions.
  • People with severe to profound hearing loss in 51 countries already benefit from the Neuro System.
  • View the full release here: https://www.businesswire.com/news/home/20210624005685/en/
    Oticon Medical announces that the US Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for the Neuro Cochlear Implant System to treat severe to profound sensorineural hearing loss.
  • The Neuro System is the first new cochlear implant technology to earn FDA premarket approval in more than 20 years.

Global Hearing Aid Devices and Equipment Market Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 17, 2021
Medical devices, Health, Otology, Otorhinolaryngology, Nervous system, Audiology, Hearing, Hearing aid, Hearing loss, Cochlear implant, Management of hearing loss

The hearing aid devices and equipment market consists of sales of hearing aid devices and equipment and related services.

Key Points: 
  • The hearing aid devices and equipment market consists of sales of hearing aid devices and equipment and related services.
  • Hearing aid devices and equipment are classified into hearing aid devices and hearing implants.
  • Hearing aid devices and equipment include: Receiver-in-the-ear hearing aids, behind-the-ear hearing aids, canal hearing aids, in-the-ear (ite) hearing aids and the hearing implants include: cochlear implants and bone-anchored systems.
  • High cost of hearing aid devices is acting as a major restraint in the hearing aid devices and equipment market.